Inhaling respirable asbestos fibres

Malignant neoplasm of the larynx - Inhaling respirable asbestos fibres Factor

Last reviewed for CCPS 18 July 2006.

Investigative Documents

Claimant Report - Respirable asbestos fibres [CR9236]

Preliminary questions [12048]

4931

there is some evidence that inhaling respirable asbestos fibres in an enclosed space may be a factor in the development of the condition under consideration.

12089 — the veteran has established the causal connection between inhaling respirable asbestos fibres in an enclosed space and operational service for the clinical onset of malignant neoplasm of the larynx.

Clinical onset and operational service [12089]

35828 the veteran inhaled respirable asbestos fibres in an enclosed space for a cumulative period of at least 1000 hours at the time material containing such fibres was being applied, removed, dislodged, cut or drilled.

35829

the veteran inhaled respirable asbestos fibres in an enclosed space for a cumulative period of at least 1000 hours at the time material containing such fibres was being applied, removed, dislodged, cut or drilled before the clinical onset of the condition under consideration.

35830

where the veteran inhaled respirable asbestos fibres in an enclosed space for a cumulative period of at least 1000 hours at the time material containing such fibres was being applied, removed, dislodged, cut or drilled before the clinical onset of the condition under consideration, the first such inhalation commenced at least 5 years before the clinical onset of the condition under consideration.

35831

operational service made a material contribution to the veteran's inhalation of respirable asbestos fibres as required by the Statement of Principles for malignant neoplasm of the larynx.